European Archives - Page 18 of 1104 - European Medical Journal

Lightening bolt on grey background

New tool supercharges lipid nanoparticle analysis

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.

20-Year Study Reveals Keys to Success in Complex Coronary Interventions

PCI for unprotected left main coronary artery shows 70% survival at 5.5 years, according to a 20-year Italian registry of 1,000 patients.

Video Endoscopic Inguinal Lymphadenectomy: A Game Changer in Penile Cancer Surgery?

VEIL outperforms OIL in reducing complications and recovery time in penile cancer surgery, offering notable clinical benefits.

Shingles Vaccine May Help Protect Against Dementia

A new study offers compelling evidence that herpes zoster vaccination may delay or prevent dementia onset.

The latest edition of EMJ Radiology

Discover the future of radiology in EMJ’s latest issue, which explores how radiology can become more sustainable, the rapid evolution of…

New PRS Spit Test Better Than UK Blood Test Screening

The study found that 74 of these participants would not have been identified through the UK’s current diagnostic pathway.

New MRI-based Model Improves Prediction of Breast Cancer Progression

New study has demonstrated that incorporating MRI-based radiomic features with clinical data significantly improves the prediction of disease upstaging in patients with DCIS.

Cut Costs for Cerebral Palsy Care with Early Intervention Telerehabilitation Model

A randomised clinical trial shows that the SMART-CP boosts rehab access for Bangladeshi children with cerebral palsy.

Prothrombin Complex Concentrate Effective in Cardiac Surgery

A new study shows that prothrombin complex concentrate (PCC) offers superior bleeding control and fewer complications than frozen plasma in cardiac surgery patients.

Oral Semaglutide Lowers Cardiovascular Risk in Type 2 Diabetes, with or without SGLT2i

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.